Collaboration: Strengthening Our Impact
At DEBRA Malaysia, we believe that collaboration is key to making a meaningful impact in the lives of those affected by Epidermolysis Bullosa (EB). Working with both local and international partners allows us to deliver our strategies more effectively and efficiently.
As an advocacy group focused on a rare disease, we understand the importance of joining forces with other organizations to amplify our efforts. We work closely with DEBRA International, sharing and learning from our collective experiences in clinical, scientific, and social settings.
This collaboration enriches our understanding and enhances our ability to provide comprehensive support and innovative solutions for EB patients. By partnering with various stakeholders, we ensure that our advocacy, research, and patient support initiatives are grounded in global best practices and tailored to meet the unique needs of our community.
Together, we strive to create a world where those living with EB have access to the care and resources they need to thrive.
Collaborate with us.
Welcoming partnership: amplifying support and awareness for EB.
DEBRA Malaysia warmly welcomes organizations, whether private or NGOs, to collaborate with us in promoting and spreading awareness about Epidermolysis Bullosa (EB) and other rare diseases.
We believe that coordinated efforts and synergy are crucial in making a significant impact and providing effective solutions to improve the lives of EB patients. Together, we can amplify our voices, share resources, and create a stronger support network to ensure that no one with EB feels alone.
Join us in our mission to bring hope, support, and better care to those affected by this challenging condition.
Academic collaboration
DEBRA Malaysia also welcomes academic collaboration in research on the scientific, clinical, and social aspects of Epidermolysis Bullosa (EB). We believe that scientific advancements can make a significant difference in the treatment, care, and overall well-being of EB patients.
By partnering with academic institutions, we aim to foster innovation and improve the social and psychological support available to those affected by this rare condition. Join us in our mission to bring hope, support, and better care through research and collaboration.
Clinical trials
Additionally, we invite companies with innovative products to work with us on clinical trials for new therapies. We can provide support in terms of facilitation and patient engagement.